In Vivo Fluorescence Imaging of IgG1 Aggregates After Subcutaneous and Intravenous Injection in Mice
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Purpose To monitor the biodistribution of IgG1 aggregates upon subcutaneous (SC) and intravenous (IV) administration in mice and measure their propensity to stimulate an early immune response.Methods A human mAb (IgG1) was fluorescently labeled, aggregated by agitation stress and injected in SKH1 mice through SC and IV routes. The biodistribution of monomeric and aggregated formulations was monitored over 47 days by fluorescence imaging and the early immune response was measured by quantifying the level of relevant cytokines in serum using a Bio-plex assay.Results The aggregates remained at the SC injection site for a longer time than monomers but after entry into the systemic circulation disappeared faster than monomers. Upon IV administration, both monomers and aggregates spread rapidly throughout the circulation, and a strong accumulation in the liver was observed for both species. Subsequent removal from the circulation was faster for aggregates than monomers. No accumulation in lymph nodes was observed after SC or IV administration. Administration of monomers and aggregates induced similar cytokine levels, but SC injection resulted in higher cytokine levels than IV administration.Conclusion These results show differences in biodistribution and residence time between IgG1 aggregates and monomers. The long residence time of aggregates at the SC injection site, in conjunction with elevated cytokine levels, may contribute to an enhanced immunogenicity risk of SC injected aggregates compared to that of monomers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The altered immune response to protein formulations that have SO microdroplets is probably associated with a T-cell-dependent B cell activation process related to IgG1 production [75, 77, 78].”
From Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review (2021) · cites this paper as [78]
Citations
Cites
Effects of protein aggregates: An immunologic perspective
Rosenberg, A. S. (2006) · The AAPS Journal · doi:10.1208/aapsj080359 · Cited by 1,355
Development trends for human monoclonal antibody therapeutics
Nelson, A. L., Dhimolea, E., & Reichert, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3229 · Cited by 1,026
Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
Wang, W., Wang, E., & Balthasar, J. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.170 · Cited by 978
Antibody Pharmacokinetics and Pharmacodynamics
Lobo, E. D., Hansen, R. J., & Balthasar, J. P. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20178 · Cited by 909
Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies
Keizer, R. J., Huitema, A. D. R., Schellens, J. H. M., & Beijnen, J. H. (2010) · Clinical Pharmacokinetics · doi:10.2165/11531280-000000000-00000 · Cited by 725
CRIg: A Macrophage Complement Receptor Required for Phagocytosis of Circulating Pathogens
Helmy, K. Y., Katschke, K. J., Gorgani, N. N., Kljavin, N. M., Elliott, J. M., Diehl, L., Scales, S. J., Ghilardi, N., & van Lookeren Campagne, M. (2006) · Cell · doi:10.1016/j.cell.2005.12.039 · Cited by 628
DeSilva, B., Smith, W., Weiner, R., Kelley, M., Smolec, J., Lee, B., Khan, M., Tacey, R., Hill, H., & Celniker, A. (2003) · Pharmaceutical Research · doi:10.1023/b:pham.0000003390.51761.3d · Cited by 623
Structure-Immunogenicity Relationships of Therapeutic Proteins
Hermeling, S., Crommelin, D. J. A., Schellekens, H., & Jiskoot, W. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000029275.41323.a6 · Cited by 617
Self-citationCarpenter, J. F., Randolph, T. W., Jiskoot, W., Crommelin, D. J. A., Russell Middaugh, C., Winter, G., Fan, Y.-X., Kirshner, S., Verthelyi, D., Kozlowski, S., et al. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21530 · Cited by 595
Self-citationPre-clinical whole-body fluorescence imaging: Review of instruments, methods and applications
Leblond, F., Davis, S. C., Valdés, P. A., & Pogue, B. W. (2010) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/j.jphotobiol.2009.11.007 · Cited by 593
Immunogenicity of therapeutic proteins: Clinical implications and future prospects
Schellekens, H. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)80075-3 · Cited by 556
Population Pharmacokinetics of Therapeutic Monoclonal Antibodies
Dirks, N. L., & Meibohm, B. (2010) · Clinical Pharmacokinetics · doi:10.2165/11535960-000000000-00000 · Cited by 500
Ismael, G., Hegg, R., Muehlbauer, S., Heinzmann, D., Lum, B., Kim, S.-B., Pienkowski, T., Lichinitser, M., Semiglazov, V., Melichar, B., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70329-7 · Cited by 351
Immunogenicity to Therapeutic Proteins: Impact on PK/PD and Efficacy
Chirmule, N., Jawa, V., & Meibohm, B. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9340-y · Cited by 335
Singh, S. K., Afonina, N., Awwad, M., Bechtold-Peters, K., Blue, J. T., Chou, D., Cromwell, M., Krause, H.-J., Mahler, H.-C., Meyer, B. K., et al. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22097 · Cited by 334
Pharmacokinetic aspects of biotechnology products
Tang, L., Persky, A. M., Hochhaus, G., & Meibohm, B. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20125 · Cited by 303
Braun, A., Kwee, L., Labow, M. A., & Alsenz, J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012193326789 · Cited by 298
Lymphatic Transport of Proteins After Subcutaneous Administration
Porter, C. J. H., & Charman, S. A. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200003)89:3<297::aid-jps2>3.0.co;2-p · Cited by 273
Joubert, M. K., Hokom, M., Eakin, C., Zhou, L., Deshpande, M., Baker, M. P., Goletz, T. J., Kerwin, B. A., Chirmule, N., Narhi, L. O., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.330902 · Cited by 268
Neonatal Fc receptor and IgG-based therapeutics
Kuo, T. T., & Aveson, V. G. (2011) · mAbs · doi:10.4161/mabs.3.5.16983 · Cited by 234
Terje Andersen, J., Bekele Daba, M., Berntzen, G., Michaelsen, T. E., & Sandlie, I. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.081828 · Cited by 197
A critical review of methods for size characterization of non-particulate protein aggregates
Philo, J. (2009) · Current Pharmaceutical Biotechnology · doi:10.2174/138920109788488815 · Cited by 196
Hermeling, S., Schellekens, H., Maas, C., Gebbink, M. F. B. G., Crommelin, D. J. A., & Jiskoot, W. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20599 · Cited by 185
Self-citationFilipe, V., Jiskoot, W., Basmeleh, A. H., Halim, A., Schellekens, H., & Brinks, V. (2012) · mAbs · doi:10.4161/mabs.22066 · Cited by 158
Self-citationBarnard, J. G., Singh, S. K., Randolph, T. W., & Carpenter, J. F. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22305 · Cited by 150
Self-citationIn vivo optical imaging and dynamic contrast methods for biomedical research
Hillman, E. M. C., Amoozegar, C., Wang, T. S., McCaslin, A. F. H., Bouchard, M. B., Mansfield, J. R., & Levenson, R. M. (2011) · Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rsta.2011.0264 · Cited by 127
Early Development of Therapeutic Biologics - Pharmacokinetics
Baumann, A. (2006) · Current Drug Metabolism · doi:10.2174/138920006774832604 · Cited by 124
van Beers, M. M. C., Sauerborn, M., Gilli, F., Brinks, V., Schellekens, H., & Jiskoot, W. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0451-4 · Cited by 115
Self-citationKagan, L., Turner, M. R., Balu‐Iyer, S. V., & Mager, D. E. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0578-3 · Cited by 109
The role of the lymphatic system in subcutaneous absorption of macromolecules in the rat model
Kagan, L., Gershkovich, P., Mendelman, A., Amsili, S., Ezov, N., & Hoffman, A. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.04.002 · Cited by 100
Hawe, A., Frieß, W., Sutter, M., & Jiskoot, W. (2008) · Analytical Biochemistry · doi:10.1016/j.ab.2008.03.050 · Cited by 91
Self-citationStructural characterization of a human Fc fragment engineered for extended serum half-life
Oganesyan, V., Damschroder, M. M., Woods, R. M., Cook, K. E., Wu, H., & Dall’Acqua, W. F. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.01.026 · Cited by 89
Wang, W., Chen, N., Shen, X., Cunningham, P. K., Fauty, S. E., Michel, K. B., Wang, B., Hong, X., Adreani, C. M., Nunes, C. N., et al. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.043604 · Cited by 86
Protein Pharmacokinetics and Metabolism
Ferraiolo, B. L., Mohler, M. A., & Gloff, C. A. (1992) · Pharmaceutical biotechnology · doi:10.1007/978-1-4899-2329-5 · Cited by 72
Charman, S. A., McLennan, D. N., Edwards, G. A., & Porter, C. J. H. (2001) · Pharmaceutical Research · doi:10.1023/a:1013046918190 · Cited by 69
Kota, J., Machavaram, K. K., McLennan, D. N., Edwards, G. A., Porter, C. J. H., & Charman, S. A. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.015669 · Cited by 67
Wu, F. P., Bhansali, S. G., Law, W., Bergey, E. J., Prasad, P. N., & Morris, M. E. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0708-6 · Cited by 61
Tasciotti, E., Godin, B., Martinez, J. O., Chiappini, C., Bhavane, R. C., Liu, X., & Mauro Ferrari, B. (2011) · Molecular Imaging · doi:10.2310/7290.2011.00011 · Cited by 60
McLennan, D. N., Porter, C. J. H., Edwards, G. A., Martin, S. W., Heatherington, A. C., & Charman, S. A. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.078790 · Cited by 57
The Role of Soluble Aggregates in the Primary Immune Response of Mice to Human Gamma Globulin
Gamble, C. N. (2009) · International Archives of Allergy and Applied Immunology · doi:10.1159/000229829 · Cited by 55
Vugmeyster, Y., DeFranco, D., Szklut, P., Wang, Q. L., & Xu, X. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21855 · Cited by 53
Mechanisms of Subcutaneous Absorption of Rituximab in Rats
Kagan, L., & Mager, D. E. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.048496 · Cited by 53
Bittner, B., Richter, W., Hourcade-Potelleret, F., McIntyre, C., Herting, F., Zepeda, M., & Schmidt, J. (2012) · Arzneimittelforschung · doi:10.1055/s-0032-1321831 · Cited by 51
Bogers, W. M. J. M., STAD, R. K., JANSSEN, D. J., van Rooijen, N., van Es, L. A., & Daha, M. R. (1991) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1991.tb05818.x · Cited by 48
McLennan, D. N., Porter, C. J. H., Edwards, G. A., Heatherington, A. C., Martin, S. W., & Charman, S. A. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9064-8 · Cited by 38
Bittner, B., Richter, W., Hourcade-Potelleret, F., McIntyre, C., Herting, F., Zepeda, M., & Schmidt, J. (2013) · Drug Research · doi:10.1055/s-0033-1357211 · Cited by 38
Effect of Treatment Regimen on the Immunogenicity of Human Interferon Beta in Immune Tolerant Mice
Kijanka, G., Jiskoot, W., Schellekens, H., & Brinks, V. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-0992-9 · Cited by 26
Self-citationLawrence, S. (2007) · Nature Biotechnology · doi:10.1038/nbt1207-1342 · Cited by 24
Some Points of the Mechanism of Filtration by the Spleen.
Wl, R. (1928) · Europe PMC (PubMed Central) · Cited by 12
Cited by
Immunogenicity of Therapeutic Protein Aggregates
Moussa, E. M., Panchal, J. P., Moorthy, B. S., Blum, J. S., Joubert, M. K., Narhi, L. O., & Topp, E. M. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.11.002 · Cited by 529
Protein aggregation – Mechanisms, detection, and control
Wang, W., & Roberts, C. J. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.08.043 · Cited by 299
Subcutaneous Absorption of Biotherapeutics: Knowns and Unknowns
Richter, W. F., & Jacobsen, B. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.059238 · Cited by 235
Aggregation of Protein Therapeutics Enhances Their Immunogenicity: Causes and Mitigation Strategies
Lundahl, M. L. E., Fogli, S., Colavita, P. E., & Scanlan, E. M. (2021) · RSC Chemical Biology · doi:10.1039/d1cb00067e · Cited by 212
Rombach-Riegraf, V., Karle, A. C., Wolf, B., Sordé, L., Koepke, S., Gottlieb, S., Krieg, J., Djidja, M.-C., Baban, A., Spindeldreher, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086322 · Cited by 165
“While the gaps in the current knowledge are founded in the limited experimental models available to scientists today, it is important to continue addressing these questions by designing novel experimental approaches [16] [11].”
Background
Metadata
- Authors
- Filipe, V., Que, I., Carpenter, J. F., Löwik, C., & Jiskoot, W.
- Affiliations
- Leiden University (NL)
- University of Colorado Anschutz (US)
- Corresponding author
- Jiskoot, Wim
- Venue
- Pharmaceutical Research
- Published
- 2013-08-15
- Volume
- 31
- Issue
- 1
- Pages
- 216-227
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W1971932455
- Cited by
- 39
- References
- 49
- Citations by year
- 2026: 3 · 2025: 3 · 2023: 2 · 2022: 1 · 2021: 5 · 2020: 3 · 2019: 4 · 2018: 3 · 2017: 3 · 2016: 6 · 2015: 1 · 2014: 5
- FWCI
- 3.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Pharmaceutical Research (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
- Life Sciences › Immunology and Microbiology › Immunology › Biosimilars and Bioanalytical Methods
- Keywords
- tissue distribution, subcutaneous injection, intravenous injection, fluorescence imaging, monoclonal antibodies, cytokine response, immunogenicity, liver accumulation, residence time, SKH-1 mice
- MeSH terms
- Animals, Antibodies, Monoclonal, Female, Fluorescence, Humans, Immunoglobulin G, Injections, Intravenous, Injections, Subcutaneous, Lymph Nodes, Tissue Distribution, Cytokines, Mice, Optical Imaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.